DOC ONE

Company

SELLAS Life Sciences Group, Inc.

Filed

July 10, 2008

Accession Number

0000315066-08-002949

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →